{"id":"7ba73986-9f68-5da5-aa5a-f7ca7a1737d9","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:aspirin-also-prevents-occlusion-in-that-model","predicate":"delays","statement":"Aspirin at 30 mg/kg fully prevented occlusion in the same model, as the 500 mg/kg nattokinase dose did.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"61ae82a6-c101-55cc-a14c-c58a0510bf42","mechanism_event_label":"Aspirin at 30 mg/kg fully prevented occlusion in the same model, as the 500 mg/kg nattokinase dose did.","subject":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"object":{"id":"36a282f4-d3f7-58de-bd77-8d841ffcd328","slug":"rat-arterial-occlusion-time","display_name":"Time to arterial occlusion after ferric-chloride injury in rat carotid artery","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"61ae82a6-c101-55cc-a14c-c58a0510bf42","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:aspirin-also-prevents-occlusion-in-that-model-event","event_type":"observed_intervention","label":"Aspirin at 30 mg/kg fully prevented occlusion in the same model, as the 500 mg/kg nattokinase dose did.","description":"Carotid artery, 35% FeCl3 injury, laser Doppler flow","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"role":"acting component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"36a282f4-d3f7-58de-bd77-8d841ffcd328","slug":"rat-arterial-occlusion-time","display_name":"Time to arterial occlusion after ferric-chloride injury in rat carotid artery","entity_type_key":"cellular_process"},"role":"component the finding is about","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"duration","value_text":"1 week of pre-treatment","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Aspirin 30 mg/kg","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The comparator arm. Equivalence of endpoint at these two doses is not equivalence of mechanism, of potency per milligram, or of bleeding risk.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Aspirin at 30 mg/kg fully prevented occlusion in the same model, as the 500 mg/kg nattokinase dose did.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation. (2013) https://pubmed.ncbi.nlm.nih.gov/24396387/ DOI: 10.5625/lar.2013.29.4.221","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vivo, oral","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Carotid artery, 35% FeCl3 injury, laser Doppler flow","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"b001736c-16b0-5861-8a34-b7b96a7f0b00","evidence_kind":"source_excerpt","locator":"Lines 312-312","start_line":312,"end_line":312,"excerpt":"Aspirin at 30 mg/kg fully prevented occlusion in the same model, as the 500 mg/kg nattokinase dose did.","model_system":"Rat","directness":"reported_statement","verification_status":"source_derived_draft","notes":"","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"41cb127c-1c23-53aa-b7d0-5ec7f6fa3c99","stable_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","document_type":"imported_text","citation_label":"Original AI-assisted curation built from a supplied entity-first document of 105 entities and 129 claims. Every reference in that document was resolved against live PubMed with its abstract read and its DOI cross-checked on 2026-09-23, and the EFSA novel-food opinion was retrieved and read in full. That check corrected two PMIDs that pointed at unrelated papers, two DOIs, and two papers recorded as carrying no erratum that do carry one; it also reversed three findings the supplied document had stated backwards. Two papers carry a published correction, recorded as such and not as a retraction. Three sources are not indexed in PubMed and are cited by what they have. Laboratory lineages are recorded, so the four papers from one group, the three from another and the two readings of a single applicant dossier cannot be counted as separate lines of support. Study-specific doses, units, populations and limitations retained; activity units are never converted between systems. Not publisher full text.","file_path":"","sha256":"34fc46e0e849d06bfa13cb099a79b50679dd6fd0de8a5a0575326afdde3259c1","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}